IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Institutional
The BSC-IRB Barcelona researcher Toni Gabaldón, vice president of the new Young Academy of Spain
Andreu Casali
Scientific
Researchers describe the first model of adult metastasis developed in the fruit fly
IRB Barcelona’s Open Day
Outreach
Witnessing a master class on public outreach: IRB Barcelona’s Open Day
Clara Campàs, founding partner of Asabys Partners, Salvador Aznar-Benitah and Valerie Vanhooren, founders of Ona Therapeutics, and Sergio Pérez, director of Sabadell Venture Capital
Innovation
Ona Therapeutics is launched
Innovation
An innovation project at IRB Barcelona receives funding to support its development for the market
Clara Campàs, founding partner of Asabys Partners, Salvador Aznar-Benitah and Valerie Vanhooren, founders of Ona Therapeutics, and Sergio Pérez, director of Sabadell Venture Capital
Innovation
The IRB Barcelona spin-off Ona Therapeutics hits the road thanks to Sabadell Asabys
Antonio Zorzano and his team at the Complex Metabolic Diseases and Mitochondria Lab have participated in this study. IRB Barcelona.
Scientific
Researchers at IRB Barcelona identify a protein that protects against non-alcoholic fatty liver disease
Structure of EGFR. Purple indicates the region recognised by mAB806. Laura Orellana.
Scientific
Researchers discover the mechanism of action of an antitumour drug used for the treatment of glioblastoma
Francesc Posas, director of IRB Barcelona.
Institutional
Francesc Posas and Modesto Orozco receive the 2018 ICREA Academia Award

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog